Proceedings of the fifth international RASopathies symposium

When development and cancer intersect

Katherine A. Rauen, Lisa Schoyer, Lisa Schill, Beth Stronach, John Albeck, Brage S. Andresen, Hélène Cavé, Michelle Ellis, Steven M. Fruchtman, Bruce D. Gelb, Christopher C. Gibson, Karen Gripp, Erin Hefner, William Y.C. Huang, Maxim Itkin, Bronwyn Kerr, Corinne M. Linardic, Martin McMahon, Beverly Oberlander, Ethan Perlstein & 17 others Nancy Ratner, Leslie Rogers, Annette Schenck, Suma Shankar, Stanislav Shvartsman, David A. Stevenson, Edward C. Stites, Philip Stork, Cheng Sun, Marc Therrien, Erik M. Ullian, Brigitte C. Widemann, Erika Yeh, Giuseppe Zampino, Martin Zenker, William Timmer, Frank McCormick

Research output: Contribution to journalArticle

Abstract

This report summarizes and highlights the fifth International RASopathies Symposium: When Development and Cancer Intersect, held in Orlando, Florida in July 2017. The RASopathies comprise a recognizable pattern of malformation syndromes that are caused by germ line mutations in genes that encode components of the RAS/mitogen-activated protein kinase (MAPK) pathway. Because of their common underlying pathogenetic etiology, there is significant overlap in their phenotypic features, which includes craniofacial dysmorphology, cardiac, cutaneous, musculoskeletal, gastrointestinal and ocular abnormalities, neurological and neurocognitive issues, and a predisposition to cancer. The RAS pathway is a well-known oncogenic pathway that is commonly found to be activated in somatic malignancies. As in somatic cancers, the RASopathies can be caused by various pathogenetic mechanisms that ultimately impact or alter the normal function and regulation of the MAPK pathway. As such, the RASopathies represent an excellent model of study to explore the intersection of the effects of dysregulation and its consequence in both development and oncogenesis.

Original languageEnglish (US)
Article numbere40632
JournalAmerican Journal of Medical Genetics, Part A
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Mitogen-Activated Protein Kinases
Neoplasms
Musculoskeletal Abnormalities
Skin Abnormalities
Eye Abnormalities
Gene Components
Germ-Line Mutation
Carcinogenesis

Keywords

  • cardio-facio-cutaneous syndrome
  • clinical trial
  • Costello syndrome
  • Legius syndrome
  • neurofibromatosis type 1
  • Noonan syndrome
  • RAS/MAPK
  • RASopathies
  • signal transduction pathway
  • therapy

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Rauen, K. A., Schoyer, L., Schill, L., Stronach, B., Albeck, J., Andresen, B. S., ... McCormick, F. (Accepted/In press). Proceedings of the fifth international RASopathies symposium: When development and cancer intersect. American Journal of Medical Genetics, Part A, [e40632]. https://doi.org/10.1002/ajmg.a.40632

Proceedings of the fifth international RASopathies symposium : When development and cancer intersect. / Rauen, Katherine A.; Schoyer, Lisa; Schill, Lisa; Stronach, Beth; Albeck, John; Andresen, Brage S.; Cavé, Hélène; Ellis, Michelle; Fruchtman, Steven M.; Gelb, Bruce D.; Gibson, Christopher C.; Gripp, Karen; Hefner, Erin; Huang, William Y.C.; Itkin, Maxim; Kerr, Bronwyn; Linardic, Corinne M.; McMahon, Martin; Oberlander, Beverly; Perlstein, Ethan; Ratner, Nancy; Rogers, Leslie; Schenck, Annette; Shankar, Suma; Shvartsman, Stanislav; Stevenson, David A.; Stites, Edward C.; Stork, Philip; Sun, Cheng; Therrien, Marc; Ullian, Erik M.; Widemann, Brigitte C.; Yeh, Erika; Zampino, Giuseppe; Zenker, Martin; Timmer, William; McCormick, Frank.

In: American Journal of Medical Genetics, Part A, 01.01.2018.

Research output: Contribution to journalArticle

Rauen, KA, Schoyer, L, Schill, L, Stronach, B, Albeck, J, Andresen, BS, Cavé, H, Ellis, M, Fruchtman, SM, Gelb, BD, Gibson, CC, Gripp, K, Hefner, E, Huang, WYC, Itkin, M, Kerr, B, Linardic, CM, McMahon, M, Oberlander, B, Perlstein, E, Ratner, N, Rogers, L, Schenck, A, Shankar, S, Shvartsman, S, Stevenson, DA, Stites, EC, Stork, P, Sun, C, Therrien, M, Ullian, EM, Widemann, BC, Yeh, E, Zampino, G, Zenker, M, Timmer, W & McCormick, F 2018, 'Proceedings of the fifth international RASopathies symposium: When development and cancer intersect', American Journal of Medical Genetics, Part A. https://doi.org/10.1002/ajmg.a.40632
Rauen, Katherine A. ; Schoyer, Lisa ; Schill, Lisa ; Stronach, Beth ; Albeck, John ; Andresen, Brage S. ; Cavé, Hélène ; Ellis, Michelle ; Fruchtman, Steven M. ; Gelb, Bruce D. ; Gibson, Christopher C. ; Gripp, Karen ; Hefner, Erin ; Huang, William Y.C. ; Itkin, Maxim ; Kerr, Bronwyn ; Linardic, Corinne M. ; McMahon, Martin ; Oberlander, Beverly ; Perlstein, Ethan ; Ratner, Nancy ; Rogers, Leslie ; Schenck, Annette ; Shankar, Suma ; Shvartsman, Stanislav ; Stevenson, David A. ; Stites, Edward C. ; Stork, Philip ; Sun, Cheng ; Therrien, Marc ; Ullian, Erik M. ; Widemann, Brigitte C. ; Yeh, Erika ; Zampino, Giuseppe ; Zenker, Martin ; Timmer, William ; McCormick, Frank. / Proceedings of the fifth international RASopathies symposium : When development and cancer intersect. In: American Journal of Medical Genetics, Part A. 2018.
@article{6916e9ed64664d6bafd6a117a79498f6,
title = "Proceedings of the fifth international RASopathies symposium: When development and cancer intersect",
abstract = "This report summarizes and highlights the fifth International RASopathies Symposium: When Development and Cancer Intersect, held in Orlando, Florida in July 2017. The RASopathies comprise a recognizable pattern of malformation syndromes that are caused by germ line mutations in genes that encode components of the RAS/mitogen-activated protein kinase (MAPK) pathway. Because of their common underlying pathogenetic etiology, there is significant overlap in their phenotypic features, which includes craniofacial dysmorphology, cardiac, cutaneous, musculoskeletal, gastrointestinal and ocular abnormalities, neurological and neurocognitive issues, and a predisposition to cancer. The RAS pathway is a well-known oncogenic pathway that is commonly found to be activated in somatic malignancies. As in somatic cancers, the RASopathies can be caused by various pathogenetic mechanisms that ultimately impact or alter the normal function and regulation of the MAPK pathway. As such, the RASopathies represent an excellent model of study to explore the intersection of the effects of dysregulation and its consequence in both development and oncogenesis.",
keywords = "cardio-facio-cutaneous syndrome, clinical trial, Costello syndrome, Legius syndrome, neurofibromatosis type 1, Noonan syndrome, RAS/MAPK, RASopathies, signal transduction pathway, therapy",
author = "Rauen, {Katherine A.} and Lisa Schoyer and Lisa Schill and Beth Stronach and John Albeck and Andresen, {Brage S.} and H{\'e}l{\`e}ne Cav{\'e} and Michelle Ellis and Fruchtman, {Steven M.} and Gelb, {Bruce D.} and Gibson, {Christopher C.} and Karen Gripp and Erin Hefner and Huang, {William Y.C.} and Maxim Itkin and Bronwyn Kerr and Linardic, {Corinne M.} and Martin McMahon and Beverly Oberlander and Ethan Perlstein and Nancy Ratner and Leslie Rogers and Annette Schenck and Suma Shankar and Stanislav Shvartsman and Stevenson, {David A.} and Stites, {Edward C.} and Philip Stork and Cheng Sun and Marc Therrien and Ullian, {Erik M.} and Widemann, {Brigitte C.} and Erika Yeh and Giuseppe Zampino and Martin Zenker and William Timmer and Frank McCormick",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/ajmg.a.40632",
language = "English (US)",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Proceedings of the fifth international RASopathies symposium

T2 - When development and cancer intersect

AU - Rauen, Katherine A.

AU - Schoyer, Lisa

AU - Schill, Lisa

AU - Stronach, Beth

AU - Albeck, John

AU - Andresen, Brage S.

AU - Cavé, Hélène

AU - Ellis, Michelle

AU - Fruchtman, Steven M.

AU - Gelb, Bruce D.

AU - Gibson, Christopher C.

AU - Gripp, Karen

AU - Hefner, Erin

AU - Huang, William Y.C.

AU - Itkin, Maxim

AU - Kerr, Bronwyn

AU - Linardic, Corinne M.

AU - McMahon, Martin

AU - Oberlander, Beverly

AU - Perlstein, Ethan

AU - Ratner, Nancy

AU - Rogers, Leslie

AU - Schenck, Annette

AU - Shankar, Suma

AU - Shvartsman, Stanislav

AU - Stevenson, David A.

AU - Stites, Edward C.

AU - Stork, Philip

AU - Sun, Cheng

AU - Therrien, Marc

AU - Ullian, Erik M.

AU - Widemann, Brigitte C.

AU - Yeh, Erika

AU - Zampino, Giuseppe

AU - Zenker, Martin

AU - Timmer, William

AU - McCormick, Frank

PY - 2018/1/1

Y1 - 2018/1/1

N2 - This report summarizes and highlights the fifth International RASopathies Symposium: When Development and Cancer Intersect, held in Orlando, Florida in July 2017. The RASopathies comprise a recognizable pattern of malformation syndromes that are caused by germ line mutations in genes that encode components of the RAS/mitogen-activated protein kinase (MAPK) pathway. Because of their common underlying pathogenetic etiology, there is significant overlap in their phenotypic features, which includes craniofacial dysmorphology, cardiac, cutaneous, musculoskeletal, gastrointestinal and ocular abnormalities, neurological and neurocognitive issues, and a predisposition to cancer. The RAS pathway is a well-known oncogenic pathway that is commonly found to be activated in somatic malignancies. As in somatic cancers, the RASopathies can be caused by various pathogenetic mechanisms that ultimately impact or alter the normal function and regulation of the MAPK pathway. As such, the RASopathies represent an excellent model of study to explore the intersection of the effects of dysregulation and its consequence in both development and oncogenesis.

AB - This report summarizes and highlights the fifth International RASopathies Symposium: When Development and Cancer Intersect, held in Orlando, Florida in July 2017. The RASopathies comprise a recognizable pattern of malformation syndromes that are caused by germ line mutations in genes that encode components of the RAS/mitogen-activated protein kinase (MAPK) pathway. Because of their common underlying pathogenetic etiology, there is significant overlap in their phenotypic features, which includes craniofacial dysmorphology, cardiac, cutaneous, musculoskeletal, gastrointestinal and ocular abnormalities, neurological and neurocognitive issues, and a predisposition to cancer. The RAS pathway is a well-known oncogenic pathway that is commonly found to be activated in somatic malignancies. As in somatic cancers, the RASopathies can be caused by various pathogenetic mechanisms that ultimately impact or alter the normal function and regulation of the MAPK pathway. As such, the RASopathies represent an excellent model of study to explore the intersection of the effects of dysregulation and its consequence in both development and oncogenesis.

KW - cardio-facio-cutaneous syndrome

KW - clinical trial

KW - Costello syndrome

KW - Legius syndrome

KW - neurofibromatosis type 1

KW - Noonan syndrome

KW - RAS/MAPK

KW - RASopathies

KW - signal transduction pathway

KW - therapy

UR - http://www.scopus.com/inward/record.url?scp=85054625782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054625782&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.40632

DO - 10.1002/ajmg.a.40632

M3 - Article

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

M1 - e40632

ER -